Close Menu

NEW YORK – Molecular diagnostics firm Fulgent Genetics announced Tuesday the Utah Department of Health has selected Fulgent to provide RT-PCR-based tests for the state's coronavirus testing initiative.

The test, which has received Emergency Use Authorization from the US Food and Drug Administration, will be administered at several fixed sites and by mobile units in select counties in the state. Tests will be processed at Fulgent's Temple City, California lab.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.